ADIPONECTIN

• Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study.
  (Bai YM, et al. Schizophr Res. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities.
  (Zhuo Q, et al. Diabetes Res Clin Pract. 2009 Apr;84(1):27-33. Epub 2009 Jan 31.)
  View Abstract
• Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1.
  (Mouquet F, et al. Eur Heart J. 2009 Apr;30(7):840-9. Epub 2009 Jan 22.)
  View Abstract

BIOMARKERS

• Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study.
  (Wild SH, et al. Atherosclerosis. 2009 Apr;203(2):604-9. Epub 2008 Aug 3.)
  View Abstract
• Plasma carboxy-terminal pro-vasopressin (Copeptin): A novel marker of insulin resistance and metabolic syndrome.
  (Saleem U, et al. J Clin Endocrinol Metab. 2009 Apr 14. [Epub ahead of print])
  View Abstract

CANCER

• Metabolic syndrome and prostate cancer: a review.
  (Nobes JP, et al. Clin Oncol (R Coll Radiol). 2009 Apr;21(3):183-91. Epub 2008 Dec 25.)
  View Abstract
• Components of metabolic syndrome and metachronous colorectal neoplasia.
  (Ashbeck EL, et al. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1134-43. Epub 2009 Mar 24.)
  View Abstract
• Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study.
  (Agnoli C, et al. Nutr Metab Cardiovasc Dis. 2009 Apr 8. [Epub ahead of print])
  View Abstract

CARDIOVASCULAR DISEASE

• Metabolic sndrome and diabetes, alone and in combination as predictors of cardiovascular disease mortality among men.
  (Church TS, et al. Diabetes Care. 2009 Apr 14. [Epub ahead of print])
  View Abstract
• Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
  (Knuiman MW, et al. Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):235-41.)
  View Abstract
• Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis.
  (Mader R, et al. Semin Arthritis Rheum. 2009 Apr;38(5):361-5. Epub 2008 Mar 4.)
  View Abstract

• Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.
  (Gupta AK, et al. Diabetes Obes Metab. 2009 Apr;11(4):330-7.)
  View Abstract
• Management of the metabolic syndrome and type 2 diabetes Through Lifestyle Modification.
  (Magkos F, et al. Annu Rev Nutr. 2009 Apr 27. [Epub ahead of print])
  View Abstract

• Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Nettleton JA, et al. Diabetes Care. 2009 Apr;32(4):688-94. Epub 2009 Jan 16.)
  View Abstract
• Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.
  (Micha R, et al. Nat Rev Endocrinol. 2009 Apr 28. [Epub ahead of print])
  View Abstract
• Dietary fructose and metabolic syndrome and diabetes.
  (Bantle JP. J Nutr. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.
  (Tsiodras S, et al. Metabolism. 2009 Apr 15. [Epub ahead of print])
  View Abstract
• Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.
  (Volek JS, et al. Lipids. 2009 Apr;44(4):297-309. Epub 2008 Dec 12.)
  View Abstract
• Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study.
  (Driessen MT, et al. Eur J Clin Nutr. 2009 Apr;63(4):536-42. Epub 2008 Feb 13.)
  View Abstract
• Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols.
  (de Moura RF, et al. Br J Nutr. 2009 Apr;101(8):1178-84. Epub 2008 Nov 14.)
  View Abstract
• The functional assessment of Alpinia pricei on metabolic syndrome induced by sucrose-containing drinking water in mice.
  (Chou YC, et al. Phytother Res. 2009 Apr;23(4):558-63.)
  View Abstract
• Metabolic syndrome and serum fatty acid patterns in serum phospholipids in hypertriglyceridemic persons with human immunodeficiency virus.
  (Woods MN, et al. Am J Clin Nutr. 2009 Apr;89(4):1180-7. Epub 2009 Feb 25.)
  View Abstract
• A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum Triacylglycerol and Non-HDL Cholesterol in Metabolic Syndrome Patients.
  (Plat J, et al. J Nutr. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults.
  (Cornish SM, et al. Appl Physiol Nutr Metab. 2009 Apr;34(2):89-98.)
  View Abstract
• Inflammatory components of adipose tissue as target for treatment of metabolic syndrome.
  (Yu R, et al. Forum Nutr. 2009;61:95-103. Epub 2009 Apr 7.)
  View Abstract
• Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome.
  (Gambineri A, et al. Nutr Metab Cardiovasc Dis. 2009 Apr 8. [Epub ahead of print])
  View Abstract

DRUG THERAPY

• Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome.
  (Kaushik SV, et al. Diabetes Metab Res Rev. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• The role of statins in the treatment of the metabolic syndrome.
  (Ott C, et al. Curr Hypertens Rep. 2009 Apr;11(2):143-9.)
  View Abstract
• Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
  (Winkler K, et al. Eur J Clin Invest. 2009 Apr 8. [Epub ahead of print])
  View Abstract
• 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
  (Jetté L, et al. Curr Opin Investig Drugs. 2009 Apr;10(4):353-8.)
  View Abstract
• Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
  (Winkler K, et al. Eur J Clin Invest. 2009 Apr 8. [Epub ahead of print])
  View Abstract

EPIDEMIOLOGY

• Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
  (Doi Y, et al. Stroke. 2009 Apr;40(4):1187-94. Epub 2009 Mar 5.)
  View Abstract
• Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly chinese.
  (Lu L, et al. Diabetes Care. 2009 Apr 14. [Epub ahead of print])
  View Abstract
• Association of C-reactive protein and metabolic syndrome in a rural Chinese population.
  (Wen J, et al. Clin Biochem. 2009 Apr 7. [Epub ahead of print])
  View Abstract
• The metabolic syndrome: A critical appraisal based on the CUORE epidemiologic study.
  (Giampaoli S, et al. Prev Med. 2009 Apr 1. [Epub ahead of print])
  View Abstract
• gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults.
  (Li M, et al. Obesity (Silver Spring). 2009 Apr;17(4):809-13. Epub 2009 Jan 15.)
  View Abstract
• Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance.
  (Esteghamati A, et al. Diabetes Res Clin Pract. 2009 Apr 7. [Epub ahead of print])
  View Abstract
• In addition to insulin resistance and obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese - A population-based study (Taichung Community Health Study, TCHS).
  (Lin WY, et al. J Atheroscler Thromb. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• Dietary intake, eating habits, and metabolic syndrome in Korean men.
  (Shin A, et al. J Am Diet Assoc. 2009 Apr;109(4):633-40.)
  View Abstract
• The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005.
  (Cho GJ, et al. Menopause. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• Association of surrogate and direct measures of adiposity with risk of metabolic syndrome in rural Chinese women.
  (Ouyang F, et al. Eur J Nutr. 2009 Apr 1. [Epub ahead of print])
  View Abstract
• Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: Results from community-based national survey.
  (Al Rashdan IR, et al. Angiology. 2009 Apr 26. [Epub ahead of print])
  View Abstract
• Prevalence of impaired glucose tolerance and the components of metabolic syndrome in Canadian Tsimshian Nation youth.
  (Zorzi A, et al. Can J Rural Med. 2009 Spring;14(2):61-7.)
  View Abstract
• Prevalence of metabolic syndrome in scholars from Bucaramanga, Colombia: a population-based study.
  (Villa-Roel C, et al. BMC Pediatr. 2009 Apr 21;9:28.)
  View Abstract
• Characteristics of reference intervals of metabolic factors in healthy Japanese: A proposal to set generation- and gender- specific diagnostic criteria for metabolic syndrome.
  (Yokoyama H, et al. J Atheroscler Thromb. 2009 Apr 30. [Epub ahead of print])
  View Abstract
• The prevalence and clinical characteristics of reflux esophagitis in Koreans and its possible relation to metabolic syndrome.
  (Song HJ, et al. J Korean Med Sci. 2009 Apr;24(2):197-202. Epub 2009 Apr 20.)
  View Abstract
• Tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese.
  (Oda E, et al. Circ J. 2009 Apr;73(4):755-9. Epub 2009 Feb 17.)
  View Abstract

EXERCISE

• Effects of an internet physical activity intervention in adults with metabolic syndrome.
  (Bosak KA, et al. West J Nurs Res. 2009 Apr 8. [Epub ahead of print])
  View Abstract
• Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.
  (Esquirol Y, et al. Chronobiol Int. 2009 Apr;26(3):544-59.)
  View Abstract

• Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.
  (Elder SJ, et al. J Lipid Res. 2009 Apr 16. [Epub ahead of print])
  View Abstract
• Nociceptin/orphanin FQ-induced food intake and cocaine amphetamine regulated transcript gene expression in strains derived from rats prone (WOKW) and resistant (Dark Agouti) to metabolic syndrome.
  (Cifani C, et al. Peptides. 2009 Apr;30(4):727-34. Epub 2008 Nov 25.)
  View Abstract
• Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression.
  (Zeman M, et al. Tohoku J Exp Med. 2009 Apr;217(4):287-93.)
  View Abstract
• Chronobiology, genetics and metabolic syndrome.
  (Garaulet M, et al. Curr Opin Lipidol. 2009 Apr;20(2):127-34.)
  View Abstract
• Genetic and environmental contributions to phenotypic components of metabolic syndrome: A population-based twin study.
  (Zhang S, et al. Obesity (Silver Spring). 2009 Apr 30. [Epub ahead of print])
  View Abstract
• Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly.
  (Valle Gottlieb MG, et al. Metab Syndr Relat Disord. 2009 Apr 3. [Epub ahead of print])
  View Abstract
• TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis.
  (Gong HP, et al. Diabetes Care. 2009 Apr 23. [Epub ahead of print])
  View Abstract

• The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study.
  (Asayama K, et al. Hypertens Res. 2009 Apr 24. [Epub ahead of print])
  View Abstract
• Hypertension in the metabolic syndrome: summary of the new position statement of the European Society of Hypertension.
  (Redon J, et al. Pol Arch Med Wewn. 2009 Apr;119(4):255-60.)
  View Abstract
• Update on the metabolic syndrome: hypertension.
  (Reynolds K, et al. Curr Hypertens Rep. 2009 Apr;11(2):150-5.)
  View Abstract

• Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons.
  (Chavez AO, et al. Cardiovasc Diabetol. 2009 Apr 23;8:22.)
  View Abstract
• Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.
  (Fortuño A, et al. J Hypertens. 2009 Apr 7. [Epub ahead of print])
  View Abstract
• Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
  (Hsu LA, et al. Metabolism. 2009 Apr 23. [Epub ahead of print])
  View Abstract
• Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents.
  (Lin LY, et al. Atherosclerosis. 2009 Apr;203(2):563-8. Epub 2008 Jul 26.)
  View Abstract
• The metabolic syndrome: insulin resistance.
  (Mikhail N. Curr Hypertens Rep. 2009 Apr;11(2):156-8.)
  View Abstract

• NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
  (Adams LA, et al. Am J Gastroenterol. 2009 Apr;104(4):861-7. Epub 2009 Mar 17.)
  View Abstract
• Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
  (Mohan V, et al. Diabetes Res Clin Pract. 2009 Apr;84(1):84-91. Epub 2009 Jan 24.)
  View Abstract
• Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.
  (Lonardo A, et al. Can J Gastroenterol. 2009 Apr;23(4):273-8.)
  View Abstract

METABOLIC SYNDROME IN MEN

• Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women.
  (Erlingsson S, et al. Metabolism. 2009 Apr 24. [Epub ahead of print])
  View Abstract
• Association of smoking status, weight change, and incident metabolic syndrome in men: A 3-year follow-up study.
  (Kim BJ, et al. Diabetes Care. 2009 Apr 23. [Epub ahead of print])
  View Abstract

METABOLIC SYNDROME IN WOMEN

• Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
  (Gaspard U. Maturitas. 2009 Apr 20;62(4):362-5. Epub 2009 Jan 7.)
  View Abstract
• Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome.
  (Ozdemir S, et al. Int J Gynaecol Obstet. 2009 Apr 24. [Epub ahead of print])
  View Abstract

• Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome.
  (Kagota S, et al. J Pharmacol Sci. 2009 Apr;109(4):556-64. Epub 2009 Apr 4.)
  View Abstract
• Castration modifies aortic vasoreactivity and serum fatty acids in a sucrose-fed rat model of metabolic syndrome.
  (Perez I, et al. Heart Vessels. 2009 Mar;24(2):147-55. Epub 2009 Apr 1.)
  View Abstract
• A new mouse model of metabolic syndrome and associated complications.
  (Wang Y, et al. J Endocrinol. 2009 Apr 27. [Epub ahead of print])
  View Abstract

OBESITY

• Obesity and the metabolic syndrome in patients with acute myocardial infarction.
  (Prasad SB, et al. Int J Cardiol. 2009 Apr 6. [Epub ahead of print])
  View Abstract
• Metabolic syndrome and its characteristics among obese patients attending an obesity clinic.
  (Termizy HM, et al. Singapore Med J. 2009 Apr;50(4):390-4.)
  View Abstract
• Coronary collaterals in obese patients: impact of metabolic syndrome.
  (Sasmaz H, et al. Angiology. 2009 Apr-May;60(2):164-8. Epub 2008 Apr 29.)
  View Abstract

• Small for gestational age status is associated with metabolic syndrome in overweight children.
  (Reinehr T, et al. Eur J Endocrinol. 2009 Apr;160(4):579-84. Epub 2009 Jan 20.)
  View Abstract
• Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype.
  (Bitsori M, et al. Int J Pediatr Obes. 2009 Apr 28:1-7. [Epub ahead of print])
  View Abstract
• Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents.
  (Daratha KB, et al. Arch Pediatr Adolesc Med. 2009 Apr;163(4):365-70.)
  View Abstract
• Does the built environment relate to the metabolic syndrome in adolescents?
  (Dengel DR, et al. Health Place. 2009 Apr 7. [Epub ahead of print])
  View Abstract
• Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006.
  (Johnson WD, et al. Arch Pediatr Adolesc Med. 2009 Apr;163(4):371-7.)
  View Abstract
• Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults.
  (Lin CY, et al. Diabetes Care. 2009 Apr;32(4):702-7. Epub 2008 Dec 29.)
  View Abstract
• Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study.
  (Koskinen T, et al. Diabet Med. 2009 Apr;26(4):354-61.)
  View Abstract
• Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort.
  (Vääräsmäki M, et al. Am J Epidemiol. 2009 May 15;169(10):1209-15. Epub 2009 Apr 10.)
  View Abstract
• Role of childhood growth on the risk of metabolic syndrome in obese men and women.
  (Salonen MK, et al. Diabetes Metab. 2009 Apr;35(2):94-100. Epub 2009 Feb 25.)
  View Abstract
• Childhood growth and future risk of the metabolic syndrome in normal-weight men and women.
  (Salonen MK, et al. Diabetes Metab. 2009 Apr;35(2):143-50. Epub 2009 Feb 25.)
  View Abstract
• Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age.
  (van der Kaay D, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1386-92. Epub 2009 Jan 21.)
  View Abstract

PSYCHOLOGICAL DISORDERS

• Metabolic syndrome: a follow-up study of acute depressive inpatients.
  (Richter N, et al. Eur Arch Psychiatry Clin Neurosci. 2009 Apr 28. [Epub ahead of print])
  View Abstract
• The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year.
  (Schorr SG, et al. J Psychiatr Res. 2009 Apr 25. [Epub ahead of print])
  View Abstract
• Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women.
  (Goldbacher EM, et al. Psychosom Med. 2009 Apr;71(3):266-72. Epub 2009 Feb 2.)
  View Abstract
• Generalized anxiety disorder Is associated with metabolic syndrome in the Vietnam experience study.
  (Carroll D, et al. Biol Psychiatry. 2009 Apr 1. [Epub ahead of print])
  View Abstract

RISK FACTORS

• Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.
  (Zuliani G, et al. Atherosclerosis. 2009 Apr;203(2):626-32. Epub 2008 Aug 12.)
  View Abstract
• Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.
  (Fadini GP, et al. Atherosclerosis. 2009 Apr 5. [Epub ahead of print])
  View Abstract
• Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT).
  (Hildrum B, et al. Diabetologia. 2009 Apr;52(4):583-90. Epub 2009 Feb 5.)
  View Abstract
• The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease.
  (Woodward M, et al. Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):210-4.)
  View Abstract
• Metabolic syndrome and oxidative stress.
  (Ando K, et al. Free Radic Biol Med. 2009 Apr 29. [Epub ahead of print])
  View Abstract
• Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.
  (Lin CC, et al. Diabetes Res Clin Pract. 2009 Apr 27. [Epub ahead of print])
  View Abstract
• Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
  (Jacobs M, et al. Eur J Clin Invest. 2009 Apr 9. [Epub ahead of print])
  View Abstract
• Inverse associations between muscle mass, strength, and the metabolic syndrome.
  (Atlantis E, et al. Metabolism. 2009 Apr 22. [Epub ahead of print])
  View Abstract
• Integration of skeletal muscle resistance arterioloar reactivity for perfusion responses in the metabolic syndrome.
  (Frisbee JC, et al. Am J Physiol Regul Integr Comp Physiol. 2009 Apr 22. [Epub ahead of print])
  View Abstract
• Redox-sensitive Akt and Src regulate coronary collateral growth in the metabolic syndrome.
  (Reed RE, et al. Am J Physiol Heart Circ Physiol. 2009 Apr 17. [Epub ahead of print])
  View Abstract
• Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.
  (Lee JS, et al. World J Gastroenterol. 2009 Apr 21;15(15):1869-75.)
  View Abstract
• Human C-reactive protein and the metabolic syndrome.
  (Devaraj S, et al. Curr Opin Lipidol. 2009 Apr 14. [Epub ahead of print])
  View Abstract
• High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
  (Ebrahimi A, et al. Diabetes Res Clin Pract. 2009 Apr 10. [Epub ahead of print])
  View Abstract
• Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides and the key components of the metabolic syndrome in Chinese subjects.
  (Yeung DC, et al. J Clin Endocrinol Metab. 2009 Apr 7. [Epub ahead of print])
  View Abstract
• Native platelet aggregation and response to aspirin in persons with the metabolic syndrome and its components.
  (Vaidya D, et al. Metab Syndr Relat Disord. 2009 Apr 8. [Epub ahead of print])
  View Abstract
• Obstructive sleep apnea, inflammation, and the metabolic syndrome.
  (Calvin AD, et al. Metab Syndr Relat Disord. 2009 Apr 3. [Epub ahead of print])
  View Abstract
• Relationship of metabolic syndrome to chronic periodontitis.
  (Li P, et al. J Periodontol. 2009 Apr;80(4):541-9.)
  View Abstract
• Ethnic, gender, and age-related differences in patients with the metabolic syndrome.
  (Razzouk L, et al. Curr Hypertens Rep. 2009 Apr;11(2):127-32.)
  View Abstract
• Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"?
  (Vischer UM, et al. Diabetes Metab. 2009 Apr;35(2):108-14. Epub 2009 Feb 23.)
  View Abstract
• Mechanisms and significance of progenitor cell reduction in the metabolic syndrome.
  (Fadini GP, et al. Metab Syndr Relat Disord. 2009 Spring;7(1):5-10.)
  View Abstract
• Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Katz R, et al. Diabetes. 2009 Apr;58(4):813-9. Epub 2009 Jan 9.)
  View Abstract
• A twin study of metabolic syndrome and autonomic tone.
  (Gehi AK, et al. J Cardiovasc Electrophysiol. 2009 Apr;20(4):422-8. Epub 2008 Nov 21.)
  View Abstract
• Kidney pathological changes in metabolic syndrome: a cross-sectional study.
  (Alexander MP, et al. Am J Kidney Dis. 2009 May;53(5):751-9. Epub 2009 Apr 1.)
  View Abstract

• Systematic screening for metabolic syndrome in consumers with severe mental illness.
  (Brunero S, et al. Int J Ment Health Nurs. 2009 Apr;18(2):144-50.)
  View Abstract
• The usefulness and cost of a shorter duration of fasting in workplace screening for glucose intolerance and metabolic syndrome.
  (McLellan RK, et al. Diabetes Res Clin Pract. 2009 Apr;84(1):e6-8. Epub 2009 Feb 1.)
  View Abstract

• Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan.
  (Chen PC, et al. Metabolism. 2009 Apr 15. [Epub ahead of print])
  View Abstract
• The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
  (Noda H, et al. Hypertens Res. 2009 Apr;32(4):289-298. Epub 2009 Feb 27.)
  View Abstract
• Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group.
  (Bang OY, et al. J Neurol Sci. 2009 Apr 25. [Epub ahead of print])
  View Abstract

TREATMENT

• Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.
  (Athyros VG, et al. Curr Med Res Opin. 2009 Apr;25(4):971-80.)
  View Abstract